0000000000449893
AUTHOR
Mr Averna
showing 50 related works from this author
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study
2004
Saturated and unsaturated free fatty acids (FFA) modulate differently HDL uptake in hepatoma HEPG2 cells
2003
Lipoprotein remnants accumulation in end-stage renal disease: evidence of an active role of heparin administration during hemodialysis
2003
Coronarografia diagnostica e conseguenti scelte terapeutiche dopo l’avvento degli stent alla rapamicina: approccio attuale ed evoluzione degli ultimi…
2003
Variations in plasma lipids and in the LDL peak particle size after acute myocardial infarction
2002
Livelli ridotti di cistatina C nell’infarto miocardico acuto vs. angina instabile, aneurisma aortico e controlli normali
2001
Clinical predictors of adverse events in a 1 year follow-up study post-PCI
2003
Chilomicronemia transitoria causa di diabete di tipo I in assenza di markers umorali di autoimmunità in una bambina di nove anni
2001
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol”
2002
Il polimorfismo genico CD14 C(-260)>T non e’ un fattore di rischio per infarto miocardico acuto
2002
Treatment of primary hypercholesterolemia: comparison of the effectiveness of different statins
2000
Diabetes, family history and extension of coronary atherosclerosis are strong predictors of adverse events post-PTCA: a 1 year follow-up study
2004
Prevalenza di fattori di rischio e variazione temporale dei parametri lipidici in una serie consecutiva di 350 infarti acuti del miocardio registrati…
2001
Effects of dialysis on the cardiovascular risk of uremic patients: increase in levels of remnant particles
2002
La simvastatina riduce le lipoproteine aterogene in pazienti con coronaropatia prematura: effetti delle statine “beyond-cholesterol”
2002
Changes in levels of triglyceride-rich lipoprotein subfractions during dialysis in uremic patients
2002
Coronarografia diagnostica: evoluzione temporale in relazione ai progressi della PTCA
2002
CD14 C(-260)>T gene polymorphism is not a risk factor for myocardial infarction
2002
Descrizione di una famiglia siciliana con iper-alfa-lipoproteinemia con deficit di CETP
2002
Accumulation of ApoE-containing triglyceride-rich lipoproteins in normolipidemic men with premature coronary artery disease
2000
Studio epidemiologico “Ustica”: bassa prevalenza delle LDL aterogene in una popolazione mediterranea
2002
Il diabete, la familiarita’ per malattie cardiovascolari e l’estensione della malattia vasale quali predittori degli eventi clinici ad 1 anno di foll…
2004
Description of a sicilian family with hyper-alpha-lipoproteinemia with deficit of CETP activity
2002
Uso degli stent medicati con rapamicina in pazienti con situazioni anatomiche o cliniche che favoriscono la restenosi: risultati del follow-up di 6 m…
2004
Nonalcoholic fatty liver and metabolic syndrome in Italy: Results from a multicentric study of the Italian Arteriosclerosis society
2013
Nonalcoholic fatty liver disease (NAFLD) is associated with all the components of metabolic syndrome (MS) and might to be considered an additional component of MS itself. The Italian Society for the Study of Atherosclerosis (SISA) in 2005 started a research project aimed to study the NAFLD, using ultrasound (US), in nondiabetic MS subjects matching at least one of the ATP III criteria for HDL-C or triglycerides [TG]. Prevalence of US-NAFLD and its associated risk factors and prevalence of hypertransaminasemia and its possible determinants were evaluated. NAFLD prevalence was 0.78. Men with steatosis compared to men without steatosis were younger (P < 0.05) with higher TG (P < 0.03), homeost…